IIQ
INOVIQ LTD FPO [IIQ]
Healthcare · ASX Small Cap
$0.2000 -4.8%
Updated 21 Jul 2026 · Signals refresh every scan
Get alerts when IIQ triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Took a hit — down 11.1% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.43, underperforming its peers
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Strong cash runway (11 quarters)
- 4C filed 2026-07-12
- Moderate P/S ratio (13.4x)
- Strong revenue growth (+35%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (3% of range)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 27% over the past year
- Revenue growing at +35% — the top line is moving in the right direction
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-6.24%/day)
Ask Scout AI about IIQ
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Change of Director's Interest Notice
NONE EXO-OC Study Outcome Investor Webinar Presentation
NONE Investor Briefing on EXO-OC Test and study outcome
LOW Quarterly Activities Report and Appendix 4C - June 2026
Recent ASX Announcements
| 2026-07-15 | Change of Director's Interest Notice |
| 2026-07-13 | EXO-OC Study Outcome Investor Webinar Presentation PRICE SENSITIVE |
| 2026-07-12 | Quarterly Activities Report and Appendix 4C - June 2026 PRICE SENSITIVE |
| 2026-07-07 | Investor Briefing on EXO-OC Test and study outcome |
| 2026-06-30 | EXO-OC algorithm and clinical study update PRICE SENSITIVE |
Key Metrics
$28.2M
Market Cap
783K
Avg Volume
0.8x
Vol Ratio
$0.19 — $0.56
52-Week Range
N/A
Short Interest
11 qtrs
Cash Runway
-34.7%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 82% |
| L | Leader vs Laggard | laggard | RS: -11 |
| I | Institutional Sponsorship | weak | Inst: 9% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
111 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track IIQ and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required